Results 1 to 10 of about 55,347 (203)

Oral erythema multiforme related to bronchodilators intake: A report of a case

open access: yesClinical Case Reports (discontinued), 2022
Erythema multiforme is a reactive inflammatory mucocutaneous disorder. It is classified into three groups: erythema multiforme minor, major, and oral erythema multiforme. The oral mucosa is mostly involved.
Sameh Sioud, Garma Maroua, Jamil Selmi
exaly   +2 more sources

Erythema Multiforme [PDF]

open access: yesEClinicalMedicine
Erythema multiforme is an inflammatory skin and mucosal disease mainly related to infectious agents such as Herpes simplex virus, Mycoplasma pneumoniae, though it can also be "idiopathic". The characteristic skin lesions are typical or atypical acral raised target lesions.
Hafsi W, Badri T.
europepmc   +4 more sources

Erythema multiforme in leprosy [PDF]

open access: yesMemorias do Instituto Oswaldo Cruz, 2012
The clinical course of leprosy is often interrupted by reactions, which are acute inflammatory episodes that can be classified as type I or type II. Type II reactions can present as cutaneous lesions that resemble erythema multiforme (EM).
Alice Machado Miranda   +5 more
doaj   +3 more sources

Atypical erythema multiforme

open access: yesThe Pan African Medical Journal, 2015
4-year-old child presented oral and genital eruptions for 2 days, he had history of herpetic stomatitis 3 days before. Examination revealed oral painful erosive lesions with genital erythematous purpuric patch mimiking atypical target-like lesions .
Fatima Zahra Elfatoiki, Soumia Chiheb
doaj   +3 more sources

Stevens-Johnson Syndrome and Erythema Multiforme Induced by Imiquimod 5% Cream. [PDF]

open access: yesDermatol Pract Concept
Introduction: Topical imiquimod is a safe and effective treatment for actinic keratoses, superficial basal cell carcinomas and anogenital warts. The treatment is commonly associated with local inflammatory reactions, while systemic side effects are rare
Salvi I   +4 more
europepmc   +2 more sources

Low-dose venlafaxine-induced erythema multiforme: a case report. [PDF]

open access: yesJ Med Case Rep
Background Venlafaxine, a serotonin–norepinephrine reuptake inhibitor, is commonly prescribed for depressive and anxiety disorders, with a safety profile comparable to selective serotonin reuptake inhibitors.
Rezapour M, Mesgarankarimi A.
europepmc   +2 more sources

Nondrug-related erythema multiforme-like eruption in a mild case of COVID-19

open access: yesJournal of the Egyptian Women’s Dermatologic Society, 2021
The diagnostic and prognostic significance of cutaneous affection in COVID-19 remains unclear. Some of the reported skin manifestations including erythema multiforme were considered associated cutaneous adverse drug reactions.
Mona El-Kalioby
doaj   +1 more source

Erythema Multiforme Is Not Always Erythema Multiforme [PDF]

open access: yesSKIN The Journal of Cutaneous Medicine, 2022
Rowell syndrome (RS) describes the rare presentation of EM like lesions found in association with a diagnosis of lupus erythematosus (LE). Major diagnostic criteria includes LE, EM, and anti-nuclear antibodies. Minor criteria includes of chilblains, anti-Ro/anti-La antibodies, and rheumatoid factor.
Hana Ahmed   +3 more
openaire   +1 more source

Can erythema multiforme be an immune sequela of IgM nephropathy? A case report

open access: yesItalian Journal of Pediatrics, 2022
A 13-year-old Chinese girl attended to our Pediatric Dermatology Unit for the appearance of itchy targetoid lesions on the trunk, face and upper limbs. A skin biopsy showed histological findings typical of erythema multiforme minor.
Francesco Messina   +4 more
doaj   +1 more source

Dilation and evacuation for fetal demise in a patient with presumed erythema multiforme major: A case report

open access: yesCase Reports in Women's Health, 2023
Background: Erythema multiforme is a rare dermatologic condition. There is limited data on the effects of erythema multiforme on the vulva, vagina, and pregnancy.
Ann Frisse   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy